A Molecularly Imprinted Synthetic Transamine
A R T I C L E S
Figure 1. R-Amino acid synthesis by transamination: (a) pyridoxamine and R-keto acid, (b) ketimine, (c) conjugated quinone-like intermediate, (d) aldimine,
and (e) pyridoxal and amino acid.
Schultz et al.,6 polypeptide-pyridoxamine chimeras by Imperali
and Roy,7 and a pyridoxamine-modified adipocyte lipid binding
protein (ALBP).8
obtained with the application of molecularly imprinted polymers
to a number of hydrolytic reactions,14 the range and catalytic
efficiencies of other reaction types have been limited. The
inherent thermal and chemical stability of these materials renders
MIPs suitable for use under conditions not conducive to
biological macromolecules.17 The flexibility offered by molec-
ular imprinting in terms of choice of template, together with
the significance of the transamination reaction, suggested the
use of molecular imprinting of TSAs for the development of a
synthetic transaminase. Previously, attempts have been made
to produce transaminase-related activities using substrate-
imprinted MIPs, although with modest results.18 In this paper,
we report the synthesis and evaluation of a MIP prepared using
a transition state analogue (TSA) for the reaction of phenylpyru-
vic acid and pyridoxamine to yield phenylalanine and pyridoxal,
the first example of such an approach to this class of reaction,
and the first example of the catalysis of a sigmatropic shift
reaction in aqueous media.
Molecular imprinting9 is a technique for the synthesis of
polymeric materials with predetermined ligand selectivity and
was perceived as an alternative approach for the development
of a synthetic transaminase. The underlying strategy entails the
use of functionalized monomers which can bind reversibly to a
template structure; the resultant complex is subsequently
incorporated into a network polymer by copolymerization in
the presence of an excess of a cross-linking monomer and an
inert solvent (porogen). The removal of the template leaves sites
of complementary shape and functionality, which are capable
of selectively rebinding the template. Molecularly imprinted
polymers (MIPs) with antibody-like recognition characteristics
have been prepared for a large number of compound classes,
and these have been studied with respect to an increasing range
of application areas.10 One area of particular interest, which to
this point in time has received relatively little attention, is their
use in the development of tools for organic synthesis.11 MIPs
have been employed as noncovalent protecting groups for
stereoselective synthesis,12 and, by analogy to the preparation
of catalytic antibodies, MIPs have been synthesized using
template substances with structures mimicking the transition
states of reactions to produce polymers with catalytic function.
Some of the reactions thus far addressed with the technique
include: dehydrofluorination,13 various hydrolyses,14 and the
Diels-Alder15 and aldol16 reactions. While success has been
Results and Discussion
Design and Synthesis of Transition State Analogues. The
reaction between pyridoxamine and phenylpyruvic acid to yield
phenylalanine and pyridoxal was selected for use in this study.
The choice of TSA for use was designed based upon transition
state structures derived from semiempirical molecular orbital
calculations (MINDO/3) performed by Andrews et al., Figure
2a.19 Their study described the mechanism of the pyridoxal-
phosphate-dependent enzyme γ-aminobutyric acid (GABA)
transaminase and led to the development of inhibitors for this
enzyme.20 The calculations indicated that in the transition state
the Schiff base is coplanar with the protonated pyridine ring
and an intramolecular hydrogen bond is present between the
phenolic hydroxyl and the Schiff base nitrogen. Protonation of
the pyridine nitrogen (pKa ∼5), instead of the more basic imine
(pKa ∼11, only suggested to be initially protonated), originates
(6) Cochran, A. G.; Pham, T.; Sugasawara, R.; Schultz, P. G. J. Am. Chem.
Soc. 1991, 113, 6670-6672.
(7) (a) Imperiali, B.; Roy, R. S. J. Am. Chem. Soc. 1994, 116, 12083-12084.
(b) Roy, R. S.; Imperiali, B. Tetrahedron Lett. 1996, 37, 2129-2132. (c)
Shogren-Knaak, M. A.; Imperiali, B. Bioorg. Med. Chem. 1999, 7, 1993-
2002.
(8) (a) Kuang, H.; Brown, M. L.; Davies, R. R.; Young, E. C.; Distefano, M.
D. J. Am. Chem. Soc. 1996, 118, 10702-10706. (b) Kuang, H.; Distefano,
M. D. J. Am. Chem. Soc. 1998, 120, 1072-1073. (c) Kuang, G.; Ha¨ring,
D.; Qi, D.; Mazhary, A.; Distefano, M. D. Bioorg. Med. Chem. Lett. 2000,
10, 2091-2095. (d) Ha¨ring, D.; Distefano, M. D. Bioorg. Med. Chem. 2001,
9, 2461-2466. (e) Ha¨ring, D.; Kuang, H.; Qi, D.; Distefano, M. D. J. Mol.
Catal. B 2001, 11, 967-970.
(9) (a) Sellergren, B., Ed. Molecularly Imprinted Polymers. Man-made Mimics
of Antibodies and Their Application in Analytical Chemistry; Elsevier:
Amsterdam, 2000. (b) Wulff, G. Chem. ReV. 2002, 102, 1-28. (c) Haupt,
K.; Mosbach, K. Chem. ReV. 2000, 100, 2495-2504.
(14) (a) Strikovsky, A. G.; Kasper, D.; Gru¨n, M.; Green, B. S.; Hradil, J.; Wulff,
G. J. Am. Chem. Soc. 2000, 122, 6295-6296. (b) Wulff, G.; Gross, T.;
Scho¨nfeld, R. Angew. Chem., Int. Ed. Engl. 1997, 36, 1961-1964. (c)
Sellergren, B.; Shea, K. J. Tetrahedron: Asymmetry 1994, 5, 1403-1406.
(d) Sellergren, B.; Karmalkar, R. N.; Shea, K. J. J. Org. Chem. 2000, 65,
4009-4027.
(15) Liu, X.-C.; Mosbach, K. Macromol. Rapid. Commun. 1997, 18, 609-615.
(16) Matsui, J.; Nicholls, I. A.; Karube, I.; Mosbach, K. J. Org. Chem. 1996,
61, 5414-5417.
(17) Svenson, J.; Nicholls, I. A. Anal. Chim. Acta 2001, 435, 19-24.
(18) (a) Wulff, G.; Vietmeier, J. Makromol. Chem., Macromol. Chem. Phys.
1989, 190, 1727-1735. (b) Andersson, L. I.; Mosbach, K. Makromol.
Chem., Rapid Commun. 1989, 10, 491-495.
(10) (a) Nicholls, I. A.; Rosengren, J. P. Bioseparation 2001, 10, 301-305. (b)
Sellergren, B. Angew. Chem., Int. Ed. 2000, 39, 1031-1039. (c) Andersson,
L. I. Bioseparation 2001, 10, 353-364. (d) Piletsky, S. A.; Panasyuk, T.
L.; Piletskaya, E. V.; Nicholls, I. A.; Ulbricht, M. J. Membr. Sci. 1999,
157, 263-278.
(11) Alexander, C.; Davidson, L.; Hayes, W. Tetrahedron 2003, 59, 2025-
2057.
(12) (a) Bystro¨m, S. E.; Bo¨rje, A.; A° kermark, B. J. Am. Chem. Soc. 1993, 115,
2081-2083. (b) Alexander, C.; Smith, C. R.; Whitcombe, M. J.; Vulfson,
E. N. J. Am. Chem. Soc. 1999, 121, 6640-6651.
(19) Iskander, M. N.; Andrews, P. R.; Winkler, D. A.; Brinkworth, R. I.; Paola,
C. D.; Cavell, S.; Issa, J. Eur. J. Med. Chem. 1991, 26, 129-136.
(20) (a) Andrews, P. R.; Gulbis, J. M.; Iskander, M. N.; Mackay, M. F. Aust. J.
Chem. 1987, 40, 1073-1081. (b) Andrews, P. R.; Iskander, M. N.; Jones,
G. P.; Winkler, D. A. Eur. J. Med. Chem. 1988, 23, 125-132.
(13) (a) Beach, J. V.; Shea, K. J. J. Am. Chem. Soc. 1994, 116, 379-380. (b)
Mu¨ller, R.; Andersson, L. I.; Mosbach, K. Makromol. Chem., Rapid
Commun. 1993, 14, 637-641.
9
J. AM. CHEM. SOC. VOL. 126, NO. 27, 2004 8555